UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 12, 2024 4:30 P.M.

Form:	S-3
CIK: 0001517022 Company Name: Akebia Therapeutics, Inc. File Number: 333-281903